Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation
Single-center Prospective Clinical Trial to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Double Auscultation
1 other identifier
interventional
225
1 country
1
Brief Summary
This study with N = 225 participants (1 cohort of a minimum of 85 and maximum of 140 participants, and an additional cohort with 85 participants) over 9 visits has been designed to assess the accuracy of Aktiia.product-us systolic and diastolic blood pressure measurements against double-auscultation reference measurements. In order to induce blood pressure changes and to simulate ambulatory scenarios, the study participants will be asked to perform a set of activities, involving body position changes and physical exercises. Additionally, this study will compare the heart rate measured by Aktiia.product-us against the reference readings provided by a finger pulse oximeter (as per ISO80601-2-61). The reliability of the auscultation readings will be controlled with simultaneous volume-clamp measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Jan 2022
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 28, 2021
CompletedStudy Start
First participant enrolled
January 11, 2022
CompletedFirst Posted
Study publicly available on registry
February 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedAugust 19, 2024
August 1, 2024
3.2 years
December 28, 2021
August 16, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Blood pressure mean value of differences
The mean value of the differences between Aktiia.product-us and double auscultation blood pressure measurements.
1 week
Blood pressure standard deviation of differences
The standard deviation of the differences between Aktiia.product-us and double auscultation blood pressure measurements.
1 week
Secondary Outcomes (1)
Heart rate root-mean-square error
1 week
Study Arms (2)
Patients 21-60yo with Aktiia.product-us
EXPERIMENTALAll study participants will wear the Aktiia.product-us during 9 visits that will be held over the span of seven days.
Patients 60-85yo with Aktiia.product-us
EXPERIMENTALAll study participants will wear the Aktiia.product-us during 9 visits that will be held over the span of seven days.
Interventions
The study will collect data from subjects by means of the device under test and collect data from subjects by means of double-auscultation, pulse oximetry and volume-clamp BP reading while subjects wear the devices at different body positions and induce BP changes, during eight visits that will be held over the span of seven days, and generate performance reports.
Eligibility Criteria
You may qualify if:
- Adult subjects (aged between 21 and 85 years old)
- Subjects can read and speak French
- Subjects can perform simple physical exercises
- Subjects agreeing to attend the totality of 9 visits
- Subjects that have signed the informed consent form
You may not qualify if:
- Clinical staff collaborating with study PI
- Subjects with tachycardia (heart rate at rest \> 120bpm)
- Subjects with atrial fibrillation
- Subjects with diabetes
- Subjects with renal dysfunctions
- Subjects with hyper-/hypothyroidism
- Subjects with pheochromocytoma
- Subjects with Raynaud's disease
- Subjects with trembling and shivering
- Subjects with interarm systolic difference \> 15 mmHg
- Subjects with interarm diastolic difference \> 10 mmHg
- Subjects with arm paralysis
- Women in known pregnancy (for ARM 1 only)
- Subjects with an arteriovenous fistula
- Subjects with arm amputations
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aktiia SAlead
Study Sites (1)
University of Lausanne Hospitals
Lausanne, 1011, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregoire Wuerzner, MD
Service of Nephrology and Hypertension CHUV
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 28, 2021
First Posted
February 11, 2022
Study Start
January 11, 2022
Primary Completion
March 31, 2025
Study Completion
March 31, 2025
Last Updated
August 19, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share